Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces mRNA translation initiation and nutrient sensing in fetal liver and skeletal muscle

This is an un-copyedited author manuscript copyrighted by The Endocrine Society. This may not be duplicated or reproduced, other that for personal use or within the rule of “Fair Use of Copyrighted Materials” (section 107, Title 17, U.S. Code) without permission of the copyright owner, The Endocrine Society. From the time of acceptance following peer review, the full text of this manuscript is made freely available by The Endocrine Society at http://www.endojournals.org/. The final copy edited article can be found at http://www.endojournals.org/. The Endocrine Society disclaims any responsibility or liability for errors or omissions in this version of the manuscript or in any version derived from it by the National Institutes of Health or other parties. The citation of this article must include the following information: author(s), article title, journal title, year of publication, and DOI.

[1]  J. Auwerx,et al.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.

[2]  J. Tong,et al.  AMP‐activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, over‐nourished sheep , 2008, The Journal of physiology.

[3]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[4]  M. Sahin,et al.  Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. , 2008, Molecular cell.

[5]  Nicholas E. Bruns,et al.  A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy , 2008, Proceedings of the National Academy of Sciences.

[6]  J. Friedman,et al.  Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep. , 2008, American journal of physiology. Endocrinology and metabolism.

[7]  P. Houghton,et al.  mTORC1 Signaling Can Regulate Growth Factor Activation of p44/42 Mitogen-activated Protein Kinases through Protein Phosphatase 2A* , 2008, Journal of Biological Chemistry.

[8]  P. Rozance,et al.  Increased insulin sensitivity and maintenance of glucose utilization rates in fetal sheep with placental insufficiency and intrauterine growth restriction. , 2007, American journal of physiology. Endocrinology and metabolism.

[9]  V. Mootha,et al.  mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.

[10]  W. Hay,et al.  Sensitivity to metabolic signals in late-gestation growth-restricted fetuses from rapidly growing adolescent sheep. , 2007, American journal of physiology. Endocrinology and metabolism.

[11]  I. McMillen,et al.  Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth , 2007, The Journal of physiology.

[12]  D. Hardie,et al.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.

[13]  R. Wilkening,et al.  Development and mechanisms of fetal hypoxia in severe fetal growth restriction. , 2007, Placenta.

[14]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[15]  S. Ozanne,et al.  Experimental IUGR and later diabetes , 2007, Journal of internal medicine.

[16]  P. Puigserver,et al.  Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.

[17]  P. Vuguin.  Animal Models for Small for Gestational Age and Fetal Programing of Adult Disease , 2007, Hormone Research in Paediatrics.

[18]  Jeffrey S. Robinson,et al.  Placental restriction of fetal growth increases insulin action, growth, and adiposity in the young lamb. , 2007, Endocrinology.

[19]  Jeffrey S. Robinson,et al.  Placental restriction of fetal growth reduces size at birth and alters postnatal growth, feeding activity, and adiposity in the young lamb. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[20]  C. Tsigos,et al.  Stress, the Endoplasmic Reticulum, and Insulin Resistance , 2006, Annals of the New York Academy of Sciences.

[21]  Brian A. Hemmings,et al.  Only Akt1 Is Required for Proliferation, while Akt2 Promotes Cell Cycle Exit through p21 Binding , 2006, Molecular and Cellular Biology.

[22]  B. Kahn,et al.  Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. , 2006, The Journal of clinical investigation.

[23]  J. Zierath,et al.  AMP-activated protein kinase signaling in metabolic regulation. , 2006, The Journal of clinical investigation.

[24]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[25]  W. Hay.  Recent observations on the regulation of fetal metabolism by glucose , 2006, The Journal of physiology.

[26]  P. Rozance,et al.  Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction. , 2006, Endocrinology.

[27]  H. Vestergaard,et al.  IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients. , 2006, Diabetes.

[28]  M. Cornier,et al.  Nutritional upregulation of p85α expression is an early molecular manifestation of insulin resistance , 2006, Diabetologia.

[29]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[30]  C. Kahn,et al.  Critical nodes in signalling pathways: insights into insulin action , 2006, Nature Reviews Molecular Cell Biology.

[31]  C. Kahn,et al.  Increased P85α Is a Potent Negative Regulator of Skeletal Muscle Insulin Signaling and Induces in Vivo Insulin Resistance Associated with Growth Hormone Excess* , 2005, Journal of Biological Chemistry.

[32]  M. Montminy,et al.  The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism , 2005, Nature.

[33]  B. V. van Bon,et al.  Programming of glucose-insulin metabolism in adult sheep after maternal undernutrition. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[34]  J. Ofrecio,et al.  Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. , 2005, Diabetes.

[35]  P. Czernichow,et al.  Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth , 2005, Diabetologia.

[36]  Jeffrey S. Robinson,et al.  Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. , 2005, Physiological reviews.

[37]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[38]  A. Vaag,et al.  Low birthweight is associated with specific changes in muscle insulin-signalling protein expression , 2005, Diabetologia.

[39]  R. Wilkening,et al.  Placental uptake and transport of ACP, a neutral nonmetabolizable amino acid, in an ovine model of fetal growth restriction. , 2004, American journal of physiology. Endocrinology and metabolism.

[40]  Mei J. Zhu,et al.  Effect of Maternal Nutrient Restriction in Sheep on the Development of Fetal Skeletal Muscle1 , 2004, Biology of reproduction.

[41]  N. Barzilai,et al.  Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. , 2004, Diabetes.

[42]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[43]  B. Hemmings,et al.  Physiological functions of protein kinase B/Akt. , 2004, Biochemical Society transactions.

[44]  R. Wilkening,et al.  The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction , 2003, The Journal of physiology.

[45]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[46]  A. Musarò,et al.  Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice , 2002, The Journal of cell biology.

[47]  J. Testa,et al.  Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. , 2002, Endocrinology.

[48]  D. Barker,et al.  The thrifty phenotype hypothesis. , 2001, British medical bulletin.

[49]  P. Rotwein,et al.  Insulin-like Growth Factor-mediated Muscle Differentiation , 2001, The Journal of Biological Chemistry.

[50]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[51]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[52]  B. Hemmings,et al.  Protein Kinase B β/Akt2 Plays a Specific Role in Muscle Differentiation* , 2001, The Journal of Biological Chemistry.

[53]  D. Keisler,et al.  Leptin regulates pulsatile luteinizing hormone and growth hormone secretion in the sheep. , 2000, Endocrinology.

[54]  M. R. Calera,et al.  Induction of Akt-2 correlates with differentiation in Sol8 muscle cells. , 1998, Biochemical and biophysical research communications.

[55]  G. Bell,et al.  Altered Hepatic Gene Expression of Enzymes Involved in Energy Metabolism in the Growth-Retarded Fetal Rat , 1996, Pediatric Research.

[56]  J. C. Ross,et al.  Placental transport and fetal utilization of leucine in a model of fetal growth retardation. , 1996, The American journal of physiology.

[57]  R. Wilkening,et al.  Placental glucose transport in heat-induced fetal growth retardation. , 1992, The American journal of physiology.

[58]  M. Divon,et al.  Intrauterine Growth Retardation: Definition, Classification, and Etiology , 1992, Clinical obstetrics and gynecology.

[59]  G. Meschia,et al.  Transplacental diffusion of ethanol under steady state conditions. , 1980, Journal of developmental physiology.

[60]  W. Hay,et al.  Utilization of substrates by the ovine placenta in vivo. , 1980, Federation proceedings.

[61]  D. Mellor,et al.  Daily changes in the curved crown-rump length of individual sheep fetuses during the last 60 days of pregnancy and effects of different levels of maternal nutrition. , 1979, Quarterly journal of experimental physiology and cognate medical sciences.

[62]  G. Meschia,et al.  Principal substrates of fetal metabolism. , 1978, Physiological reviews.

[63]  M. D. Jones,et al.  Placental production and foetal utilisation of lactate and pyruvate , 1975, Nature.

[64]  J. Friedman,et al.  Insulin is required for amino acid stimulation of dual pathways for translational control in skeletal muscle in the late-gestation ovine fetus. , 2009, American journal of physiology. Endocrinology and metabolism.

[65]  W. Hay,et al.  Leucine metabolism in chronically hypoglycemic hypoinsulinemic growth-restricted fetal sheep. , 1997, The American journal of physiology.

[66]  W. Oh,et al.  Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. , 1997, The American journal of physiology.

[67]  H. S. Brar,et al.  Classification of intrauterine growth retardation , 1988 .